The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue
Open accessAbstract
BACKGROUND: Extremely dense breast tissue is a risk factor for breast cancer and limits the detection of cancer with mammography. Data are needed on the use of supplemental magnetic resonance imaging (MRI) to improve early detection and reduce interval breast cancers in such patients. METHODS: In this multicenter, randomized, controlled trial in the Netherlands, we assigned 40,373 women between the ages of 50 and 75 years with extremely dense breast tissue and normal results on screening mammography to a group that was invited to undergo supplemental MRI or to a group that received mammography screening only. The groups were assigned in a 1:4 ratio, with 8061 in the MRI-invitation group and 32,312 in the mammography-only group. The primary outcome was the between-group difference in the incidence of interval cancers during a 2-year screening period. RESULTS: The interval-cancer rate was 2.5 per 1000 screenings in the MRI-invitation group and 5.0 per 1000 screenings in the mammography-only group, for a difference of 2.5 per 1000 screenings (95% confidence interval [CI], 1.0 to 3.7; P<0.001). Of the women who were invited to undergo MRI, 59% accepted the invitation. Of the 20 interval cancers that were diagnosed in the MRI-invitation group, 4 were diagnosed in the women who actually underwent MRI (0.8 per 1000 screenings) and 16 in those who did not accept the invitation (4.9 per 1000 screenings). The MRI cancer-detection rate among the women who actually underwent MRI screening was 16.5 per 1000 screenings (95% CI, 13.3 to 20.5). The positive predictive value was 17.4% (95% CI, 14.2 to 21.2) for recall for additional testing and 26.3% (95% CI, 21.7 to 31.6) for biopsy. The false positive rate was 79.8 per 1000 screenings. Among the women who underwent MRI, 0.1% had either an adverse event or a serious adverse event during or immediately after the screening. CONCLUSIONS: The use of supplemental MRI screening in women with extremely dense breast tissue and normal results on mammography resulted in the diagnosis of significantly fewer interval cancers than mammography alone during a 2-year screening period. (Funded by the University Medical Center Utrecht and others; DENSE ClinicalTrials.gov number, NCT01315015.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Causal Effects Using Instrumental Variables
Angrist, J. D., Imbens, G. W., & Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476902 · Cited by 4,230
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Mammographic Density and the Risk and Detection of Breast Cancer
Boyd, N. F., Guo, H., Martin, L. J., Sun, L., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062790 · Cited by 2,478
Breast imaging reporting and data system (BI-RADS)
Liberman, L., & Menell, J. H. (2002) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(01)00017-3 · Cited by 2,155
Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis
McCormack, V. A., & dos Santos Silva, I. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0034 · Cited by 2,143
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Self-citationBerg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00009 · Cited by 1,248
A New Design for Randomized Clinical Trials
Zelen, M. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905313002203 · Cited by 1,055
Mandelson, M. T. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1081 · Cited by 1,031
MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer
Lehman, C. D., Gatsonis, C., Kuhl, C. K., Hendrick, R. E., Pisano, E. D., Hanna, L., Peacock, S., Smazal, S. F., Maki, D. D., Julian, T. B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065447 · Cited by 945
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study
Kuhl, C. K., Schrading, S., Bieling, H. B., Wardelmann, E., Leutner, C. C., Koenig, R., Kuhn, W., & Schild, H. H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61232-x · Cited by 711
Ohuchi, N., Suzuki, A., Sobue, T., Kawai, M., Yamamoto, S., Zheng, Y.-F., Shiono, Y. N., Saito, H., Kuriyama, S., Tohno, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00774-6 · Cited by 616
Mandelblatt, J. S., Cronin, K. A., Bailey, S., Berry, D. A., de Koning, H. J., Draisma, G., Huang, H., Lee, S. J., Munsell, M., Plevritis, S. K., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00010 · Cited by 605
Self-citationSystematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
Warner, E., Messersmith, H., Causer, P., Eisen, A., Shumak, R., & Plewes, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00007 · Cited by 564
Pisano, E. D., Hendrick, R. E., Yaffe, M. J., Baum, J. K., Acharyya, S., Cormack, J. B., Hanna, L. A., Conant, E. F., Fajardo, L. L., Bassett, L. W., et al. (2008) · Radiology · doi:10.1148/radiol.2461070200 · Cited by 464
Melnikow, J., Fenton, J. J., Whitlock, E. P., Miglioretti, D. L., Weyrich, M. S., Thompson, J. H., & Shah, K. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1789 · Cited by 376
Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer
Kuhl, C. K., Strobel, K., Bieling, H., Leutner, C., Schild, H. H., & Schrading, S. (2017) · Radiology · doi:10.1148/radiol.2016161444 · Cited by 350
Mammographic density, breast cancer risk and risk prediction
Vachon, C. M., van Gils, C. H., Sellers, T. A., Ghosh, K., Pruthi, S., Brandt, K. R., & Pankratz, V. S. (2007) · Breast Cancer Research · doi:10.1186/bcr1829 · Cited by 346
Self-citationADJUSTING FOR NON-COMPLIANCE AND CONTAMINATION IN RANDOMIZED CLINICAL TRIALS
CUZICK, J., EDWARDS, R., & SEGNAN, N. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970515)16:9<1017::aid-sim508>3.0.co;2-v · Cited by 309
Visvanathan, K., Chlebowski, R. T., Hurley, P., Col, N. F., Ropka, M., Collyar, D., Morrow, M., Runowicz, C., Pritchard, K. I., Hagerty, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5179 · Cited by 286
Lord, S. J., Lei, W., Craft, P., Cawson, J. N., Morris, I., Walleser, S., Griffiths, A., Parker, S., & Houssami, N. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.06.007 · Cited by 281
Mandelblatt, J. S., Stout, N. K., Schechter, C. B., van den Broek, J. J., Miglioretti, D. L., Krapcho, M., Trentham-Dietz, A., Munoz, D., Lee, S. J., Berry, D. A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1536 · Cited by 281
Self-citationLord, S. J., Irwig, L., & Simes, R. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-11-200606060-00011 · Cited by 268
Volumetric breast density estimation from full-field digital mammograms
van Engeland, S., Snoeren, P. R., Huisman, H., Boetes, C., & Karssemeijer, N. (2006) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2005.862741 · Cited by 238
Self-citationPatient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis
Ropka, M. E., Keim, J., & Philbrick, J. T. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.8077 · Cited by 230
Dunn, G., Maracy, M., & Tomenson, B. (2005) · Statistical Methods in Medical Research · doi:10.1191/0962280205sm403oa · Cited by 201
Tabár, L., Yen, A. M.-F., Wu, W. Y.-Y., Chen, S. L.-S., Chiu, S. Y.-H., Fann, J. C.-Y., Ku, M. M.-S., Smith, R. A., Duffy, S. W., & Chen, T. H.-H. (2015) · The Breast Journal · doi:10.1111/tbj.12354 · Cited by 198
The health status of the Dutch population as assessed by the EQ-6D
Hoeymans, N., Lindert, H. V., & Westert, G. P. (2005) · Quality of Life Research · doi:10.1007/s11136-004-1214-z · Cited by 188
Volumetric breast density affects performance of digital screening mammography
Wanders, J. O. P., Holland, K., Veldhuis, W. B., Mann, R. M., Pijnappel, R. M., Peeters, P. H. M., van Gils, C. H., & Karssemeijer, N. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4090-7 · Cited by 166
Self-citationThe MISCAN simulation program for the evaluation of screening for disease
Habbema, J. D. F., van Oortmarssen, G. J., Lubbe, J. T. N., & van der Maas, P. J. (1985) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(85)90048-3 · Cited by 149
Mammographic Density and Estrogen Receptor Status of Breast Cancer
Ziv, E., Tice, J. A., Smith‐Bindman, R., Shepherd, J., Cummings, S. R., & Kerlikowske, K. M. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.2090.13.12 · Cited by 122
Estimating Intervention Effects of Prevention Programs: Accounting for Noncompliance
Stuart, E. A., Perry, D. F., Le, H., & Ialongo, N. S. (2008) · Prevention Science · doi:10.1007/s11121-008-0104-y · Cited by 117
Tilanus‐Linthorst, M. M. A., Obdeijn, I.-M., Hop, W. C. J., Causer, P. A., Leach, M. O., Warner, E., Pointon, L. J., Hill, K. A., Klijn, J. G. M., Warren, R. M. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0689 · Cited by 113
Emaus, M. J., Bakker, M. F., Peeters, P. H. M., Loo, C. E., Mann, R. M., de Jong, M. D. F., Bisschops, R. H. C., Veltman, J., Duvivier, K. M., Lobbes, M. B. I., et al. (2015) · Radiology · doi:10.1148/radiol.2015141827 · Cited by 108
Self-citationKriege, M., Brekelmans, C. T. M., Obdeijn, I. M., Boetes, C., Zonderland, H. M., Muller, S. H., Kok, T., Manoliu, R. A., Besnard, A. P. E., Tilanus‐Linthorst, M. M. A., et al. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9230-z · Cited by 97
Abujudeh, H. H., Kosaraju, V., & Kaewlai, R. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.3099 · Cited by 91
The Mammogram That Cried Wolfe
Kerlikowske, K. M. (2007) · New England Journal of Medicine · doi:10.1056/nejme068244 · Cited by 85
Ultrasound for breast cancer screening and staging
Gordon, P. B. (2002) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(01)00014-8 · Cited by 76
Impact of screening for breast cancer in high-risk women on health-related quality of life
Rijnsburger, A. J., Essink‐Bot, M., van Dooren, S., Borsboom, G. J. J. M., Seynaeve, C., Bartels, C. C. M., Klijn, J. G. M., Tibben, A., & de Koning, H. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601912 · Cited by 75
Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire
Brodersen, J., & Thorsen, H. (2008) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430802542508 · Cited by 63
Evaluating new screening tests for breast cancer
Irwig, L., Houssami, N., Armstrong, B. K., & Glasziou, P. (2006) · BMJ · doi:10.1136/bmj.332.7543.678 · Cited by 58
Cost‐effectiveness of digital mammography screening before the age of 50 in T he N etherlands
Sankatsing, V. D. V., Heijnsdijk, E. A. M., van Luijt, P. A., van Ravesteyn, N. T., Fracheboud, J., & de Koning, H. J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29572 · Cited by 45
Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm
Colletti, P. M. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.08.1327 · Cited by 35
Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy
Fernández‐Nogueira, P., Mancino, M., Fuster, G., Bragado, P., de Puig, M. P., Gascón, P., Casado, F. J., & Carbó, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030776 · Cited by 15
Cited by
Nia, H. T., Munn, L. L., & Jain, R. K. (2020) · Science · doi:10.1126/science.aaz0868 · Cited by 855
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Nicholson, W. K., Silverstein, M., Wong, J. B., Barry, M. J., Chelmow, D., Coker, T. R., Davis, E. M., Jaén, C. R., Krousel-Wood, M., et al. (2024) · JAMA · doi:10.1001/jama.2024.5534 · Cited by 463
Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR
Monticciolo, D. L., Newell, M. S., Moy, L., Lee, C. S., & Destounis, S. V. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.04.002 · Cited by 290
Toward robust mammography-based models for breast cancer risk
Yala, A., Mikhael, P. G., Strand, F., Lin, G., Smith, K., Wan, Y.-L., Lamb, L., Hughes, K., Lehman, C., & Barzilay, R. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba4373 · Cited by 287
How does artificial intelligence in radiology improve efficiency and health outcomes?
van Leeuwen, K. G., de Rooij, M., Schalekamp, S., van Ginneken, B., & Rutten, M. J. C. M. (2022) · Pediatric Radiology · doi:10.1007/s00247-021-05114-8 · Cited by 236
Metadata
- Authors
- Bakker, M. F., de Lange, S. V., Pijnappel, R. M., Mann, R. M., Peeters, P. H. M., Monninkhof, E. M., Emaus, M. J., Loo, C. E., Bisschops, R. H. C., Lobbes, M. B. I., de Jong, M. D. F., Duvivier, K. M., Veltman, J., Karssemeijer, N., de Koning, H. J., van Diest, P. J., Mali, W. P. T. M., van den Bosch, M. A. A. J., Veldhuis, W. B., & van Gils, C. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-11-28
- Volume
- 381
- Issue
- 22
- Pages
- 2091-2102
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2991330623
- Cited by
- 702
- References
- 49
- Type
- supplementary materials
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.